AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 26-50/55
ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROMES - DURABLE RESPONSE IN A YOUNG PATIENT
Authors: SPIRITI MAA LATAGLIATA R PETTI MC
Citation: Maa. Spiriti et al., ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROMES - DURABLE RESPONSE IN A YOUNG PATIENT, Haematologica, 81(4), 1996, pp. 381-382
PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: KEATING S SUCIU S DEWITTE T MANDELLI F WILLEMZE R RESEGOTTI L BROCCIA G THALER J LABAR B DAMASIO E BIZZI B ROTOLI B VEKHOFF A MUUS P PETTI MC DARDENNE M SOLBU G VEGNA ML ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON
Authors: PETTI MC LATAGLIATA R AVVISATI G SPIRITI MAA MONTEFUSCO E SPADEA A MANDELLI F
Citation: Mc. Petti et al., TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH LYMPHOBLASTOID ALPHAS INTERFERON, British Journal of Haematology, 95(2), 1996, pp. 364-367
AIDA (ALL-TRANS-RETINOIC ACID PLUS IDARUBICIN) IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - A -ITALIANO-MALATTIE-EMATOLOGICHE-MALIGNE-DELLADULTO (GIMEMA) PILOT-STUDY
Authors: AVVISATI G LOCOCO F DIVERIO D FALDA M FERRARA F LAZZARINO M RUSSO D PETTI MC MANDELLI F
Citation: G. Avvisati et al., AIDA (ALL-TRANS-RETINOIC ACID PLUS IDARUBICIN) IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - A -ITALIANO-MALATTIE-EMATOLOGICHE-MALIGNE-DELLADULTO (GIMEMA) PILOT-STUDY, Blood, 88(4), 1996, pp. 1390-1398
THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS
Authors: LATAGLIATA R PETTI MC DIVERIO D FAZI P MECAROCCI S MONTEFUSCO E REDI R SPADEA A TORROMEO MC AVVISATI G
Citation: R. Latagliata et al., THE ROLE OF ALL-TRANS-RETINOIC ACID (ATRA) TREATMENT IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS AGED GREATER-THAN 60 YRS, Blood, 88(10), 1996, pp. 3425-3425
LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA
Authors: MUUS P ZITTOUN R HAYAT M MANDELLI F WILLEMZE R DEWITTE T STRYCKMANS P LABAR B BERNEMAN Z ARCHIMBAUD E PETTI MC JEHN U SOLBU G DARDENNE M SUCIU S
Citation: P. Muus et al., LONG-TERM SURVIVORS AFTER AML - FOLLOW-UP ON SURVIVAL AND LATE SIDE-EFFECTS OF THE AML5, AML6 AND AML8 STUDIES OF THE EORTC LEUKEMIA COOPERATIVE GROUP AND THE GIMEMA, Blood, 88(10), 1996, pp. 311-311
MULTIDRUG-RESISTANCE EXPRESSION AND PROLIFERATIVE STUDIES IN POOR-RISK ACUTE MYELOID-LEUKEMIA TREATED WITH THE FLAG (G-CSF PLUS FLUDARABINEAND ARA-C) REGIMEN
Authors: TAFURI A DEFELICE L PETRUCCI MT MASCOLO MG RICCIARDI MR CILIBERTI C MARTELLI MP PETTI MC
Citation: A. Tafuri et al., MULTIDRUG-RESISTANCE EXPRESSION AND PROLIFERATIVE STUDIES IN POOR-RISK ACUTE MYELOID-LEUKEMIA TREATED WITH THE FLAG (G-CSF PLUS FLUDARABINEAND ARA-C) REGIMEN, Cytokines and molecular therapy, 1(4), 1995, pp. 301-307
MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA
Authors: VISANI G PETTI MC CENACCHI A MANFROI S TOSI P SPADEA A LATAGLIATA R AMADORI S MANDELLI F TURA S
Citation: G. Visani et al., MEC (MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE CYTARABINE) - AN EFFECTIVE INDUCTION REGIMEN FOR PREVIOUSLY UNTREATED ACUTE NONLYMPHOCYTIC LEUKEMIA, Leukemia & lymphoma, 19(5-6), 1995, pp. 447-451
IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: DEFABRITIIS P AMADORI S PETTI MC MANCINI M MONTEFUSCO E PICARDI A GEISER T CAMPBELL K CALABRETTA B MANDELLI F
Citation: P. Defabritiis et al., IN-VITRO PURGING WITH BCR-ABL ANTISENSE OLIGODEOXYNUCLEOTIDES DOES NOT PREVENT HEMATOLOGIC RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Leukemia, 9(4), 1995, pp. 662-664
RAPID AMELIORATION OF THE COAGULOPATHY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH A COMBINATION OF ALL-TRANS-RETINOIC ACID (ATRA) PLUS IDARUBICIN (AIDA PROTOCOL)
Authors: AVVISATI G DRAGONI F CHISTOLINI A MAZZUCCONI MG PALLOTTA A LATAGLIATA R PETTI MC MANDELLI F
Citation: G. Avvisati et al., RAPID AMELIORATION OF THE COAGULOPATHY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH A COMBINATION OF ALL-TRANS-RETINOIC ACID (ATRA) PLUS IDARUBICIN (AIDA PROTOCOL), Thrombosis and haemostasis, 73(6), 1995, pp. 1432-1432
IS AGGRESSIVE CHEMOTHERAPY THE BEST CHOICE FOR PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER MYELODYSPLASTIC SYNDROMES
Authors: LATAGLIATA R SPIRITI MAA AVVISATI G DEGREGORIS C FAZI P SPADEA A PETTI MC
Citation: R. Latagliata et al., IS AGGRESSIVE CHEMOTHERAPY THE BEST CHOICE FOR PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER MYELODYSPLASTIC SYNDROMES, Leukemia research, 19(3), 1995, pp. 213-217
AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA
Authors: ZITTOUN RA MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L LEONI F DAMASIO E VISANI G PAPA G CARONIA F HAYAT M STRYCKMANS P ROTOLI B LEONI P PEETERMANS ME DARDENNE M VEGNA ML PETTI MC SOLBU G SUCIU S
Citation: Ra. Zittoun et al., AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(4), 1995, pp. 217-223
INTERLEUKIN-3 PRIMING IN ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: TAFURI A DEFELICE L GOODACRE A FENU S PETRUCCI MT VALENTINI T ALIMENA G PETTI MC MELONI G MANDELLI F ANDREEFF M
Citation: A. Tafuri et al., INTERLEUKIN-3 PRIMING IN ACUTE MYELOID-LEUKEMIA PATIENTS, British Journal of Haematology, 91(1), 1995, pp. 234-244
EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: ZITTOUN R MANDELLI E WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI R VISANI G CARONIA E STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA LP PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML), Leukemia & lymphoma, 13, 1994, pp. 101-101
POOR-RISK AML WITH HIGH RHODAMINE-123 EFFLUX VALUE UNDERGOING FLAG REGIMEN - EVALUATION OF PROLIFERATIVE CHANGES INDUCED BY G-CSF
Authors: TAFURI A DEFELICE L PETRUCCI MT MASCOLO MG VALENTINI T SPADEA A MANDELLI F PETTI MC
Citation: A. Tafuri et al., POOR-RISK AML WITH HIGH RHODAMINE-123 EFFLUX VALUE UNDERGOING FLAG REGIMEN - EVALUATION OF PROLIFERATIVE CHANGES INDUCED BY G-CSF, Blood, 84(10), 1994, pp. 10000046-10000046
PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS
Authors: SPADEA A PETTI MC SPIRITI MAA AVVISATI G LATAGLIATA R MONTEFUSCO E MANDELLI F
Citation: A. Spadea et al., PIPOBROMAN IN POLYCYTHEMIA-VERA PATIENTS - A RETROSPECTIVE ANALYSIS, Blood, 84(10), 1994, pp. 10000058-10000058
PREDICTIVE VALUE OF IN-VITRO TESTS FOR RESPONSE TO TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROME
Authors: DEFELICE L VALENTINI T CILIBERTI C PETTI MC SPIRITI A MANDELLI F
Citation: L. Defelice et al., PREDICTIVE VALUE OF IN-VITRO TESTS FOR RESPONSE TO TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROME, Blood, 84(10), 1994, pp. 10000129-10000129
EFFECTS OF MAST-CELL GROWTH-FACTOR ON ARA-C MEDIATED ACUTE MYELOID-LEUKEMIA CELL-KILLING
Authors: TAFURI A DEFELICE L MASCOLO MG VALENTINI T PETRUCCI MT PETTI MC
Citation: A. Tafuri et al., EFFECTS OF MAST-CELL GROWTH-FACTOR ON ARA-C MEDIATED ACUTE MYELOID-LEUKEMIA CELL-KILLING, Stem cells, 11, 1993, pp. 88-92
WHAT IS THE BEST TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA
Authors: AVVISATI G PETTI MC MANDELLI F
Citation: G. Avvisati et al., WHAT IS THE BEST TREATMENT FOR ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia & lymphoma, 11, 1993, pp. 29-35
POLYCYTHEMIA-VERA AND CEREBRAL BLOOD-FLOW - A PRELIMINARY-STUDY WITH TRANSCRANIAL DOPPLER
Authors: FIERMONTE G SPIRITI MAA LATAGLIATA R PETTI MC GIACOMINI P
Citation: G. Fiermonte et al., POLYCYTHEMIA-VERA AND CEREBRAL BLOOD-FLOW - A PRELIMINARY-STUDY WITH TRANSCRANIAL DOPPLER, Journal of internal medicine, 234(6), 1993, pp. 599-602
MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA
Authors: SPADEA A PETTI MC FAZI P VEGNA ML ARCESE W AVVISATI G SPIRITI MAA LATAGLIATA R MELONI G TESTI AM AMADORI S MANDELLI F
Citation: A. Spadea et al., MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA, Leukemia, 7(4), 1993, pp. 549-552
PILOT-STUDY OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) IN THE TREATMENT OF POOR-PROGNOSIS ACUTE MYELOGENOUS LEUKEMIA PATIENTS - PRELIMINARY-RESULTS
Authors: PETTI MC MANDELLI F ZAGONEL V DEGREGORIS C MEROLA MC LATAGLIATA R GATTEI V FAZI P MONFARDINI S PINTO A
Citation: Mc. Petti et al., PILOT-STUDY OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) IN THE TREATMENT OF POOR-PROGNOSIS ACUTE MYELOGENOUS LEUKEMIA PATIENTS - PRELIMINARY-RESULTS, Leukemia, 7, 1993, pp. 36-41
INVITRO AND INVIVO EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) ON CLONOGENIC CELLS FROM ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: GATTEI V ALDINUCCI D PETTI MC DAPONTE A ZAGONEL V PINTO A
Citation: V. Gattei et al., INVITRO AND INVIVO EFFECTS OF 5-AZA-2'-DEOXYCYTIDINE (DECITABINE) ON CLONOGENIC CELLS FROM ACUTE MYELOID-LEUKEMIA PATIENTS, Leukemia, 7, 1993, pp. 42-48
ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS
Authors: SPIRITI MAA LATAGLIATA R AVVISATI G BATTISTEL V MONTEFUSCO E SPADEA A PETTI MC
Citation: Maa. Spiriti et al., ERYTHROPOIETIN TREATMENT OF IDIOPATHIC MYELOFIBROSIS, Haematologica, 78(6), 1993, pp. 371-373
RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES - AN INTERIM-REPORT
Authors: SPIRITI MAA PETTI MC LATAGLIATA R AVVISATI G DEGREGORIS C PROIA S FAZI P JAALOUK G MANCINI M SPADEA A VILLA R MANDELLI F
Citation: Maa. Spiriti et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES - AN INTERIM-REPORT, Haematologica, 78(2), 1993, pp. 123-126
Risultati: 1-25 | 26-50 | 51-55